Die Aktie von Gilead Sciences tritt nach einem schwachen ...
Pfizer Inc. is evolving from a blockbuster vaccine story ...
Die Genmab-Aktie steckt nach starken Jahren in einer Konsolidierung. ...
AbbVie’s share price has traded sideways over the past ...
Piramal Pharma Solutions demonstriert Engagement fĂĽr Spitzenleistungen ...
Piramal Pharma Solutions Demonstrates Commitment to Excellence ...
OSE Immunotherapeutics übernimmt höhere Entwicklungskosten ...
Cerevel Therapeutics Holdings US15678U1280
Korrekturmeldung: Defence Therapeutics gibt die Einrichtung ...
Defense Therapeutics gibt die Einrichtung eines Scientific ...
Piramal Pharma Solutions erfĂĽllt regulatorische Anforderungen ...
Piramal Pharma Solutions Achieves Regulatory Compliance ...
EQS-News: Heidelberg Pharma gibt Veränderungen im Vorstand ...
Heidelberg Pharma gibt Veränderungen im Vorstand bekannt ...
Heidelberg Pharma Announces Changes to the Executive Management ...
EQS-Adhoc: Heidelberg Pharma gibt Veränderungen im Vorstand ...
Heidelberg Pharma gibt Veränderungen im Vorstand bekannt ...
Heidelberg Pharma Announces Changes to the Executive Management ...
EQS-News: Die Biokonjugat-Anlage von Piramal Pharma Solutions ...
Die Biokonjugat-Anlage von Piramal Pharma Solutions in Grangemouth ...
Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth ...
Clinical Pipeline Progress at CytomX
Der SPDR S&P 500 High Dividend ETF verzeichnet deutliche ...
Strong Financial Performance Exceeds Expectations
Biotech-Unternehmen Genmab präsentiert bei der ASH-Jahrestagung ...
TAGESVORSCHAU: Termine am 31. Oktober 2025
Piramal Pharma Solutions formalisiert Partnerschaft mit ...
Der Vanguard FTSE All-World High Dividend Yield UCITS ETF ...
TAGESVORSCHAU: Termine am 31. Oktober 2025
Piramal Pharma Solutions Formalizes Partnership with IntoCell ...
Immunology Portfolio Drives Exceptional Performance
Financial Headwinds Prompt Guidance Revision
Earnings Report Looms Amid Cautious Forecasts
Unexpected R&D Expenses Trigger Guidance Reduction
Defence Therapeutics ernennt Dr. Mark Lambermon zum Head ...
Pfizer vereinbart mit US-Regierung reduzierte Arzneimittelpreise ...
Rheuma in Ă–sterreich: Patient:innen fordern mehr Mitsprache ...
Cybin gibt Update zur Neuropsychiatrie-Plattform und bevorstehenden ...
Der Schwab U.S. Dividend Equity ETF setzt mit Top-Positionen ...
Market Enthusiasm and Revised Financial Forecasts
NurExone Biologic gibt Unternehmensupdates bekannt darunter ...
Strategic Timing for... Read more...
FĂĽhrungswechsel bei Amgen in Deutschland: Carolina Correa ...
A Vote of Confidence Through Dividend Growth
Der Schwab U.S. Dividend Equity ETF hat seine Portfoliozusammensetzung ...
Strategische Ăśbernahmen als Wachstumstreiber
Defence Therapeutics ernennt Dr. Amie Phinney zur Strategie- ...
Piramal Pharma Solutions aide George Medicines Ă mettre ...
CAR-T Cell Therapy Market to Reach USD 11 142.53 million ...
Piramal Pharma publica su informe de sostenibilidad del ...
12.6% CAGR for Cancer Drugs Market to Reach US$516.15 billion ...
Pediatric Relapsed/Refractory Neuroblastoma Market is on ...
Cosmetic Implants Market to Grow at a Robust CAGR of 9.67% ...
Oncology Drugs Market worth $520 billion by 2033 - Exclusive ...
Piramal Pharma Limited annonce ses résultats consolidés ...
Hyaluronic Acid Raw Material Market is projected to grow ...
Spinal Cord Injury Market Likely to Exhibit Substantial ...
BaseLaunch announces a new partnership with AbbVie. BaseLaunch ...
Dragonfly hat nach der Verabreichung des ersten Patienten ...
Regulatory T-cells Market to Observe Significant Growth ...
Dyspareunia Treatment Market to Hit $1 035.4 million by ...
Piramal Pharma Limited Announces Results for Q4 and FY2025 ...
Dragonfly kĂĽndigt klinische Zusammenarbeit zur Erforschung ...
Dragonfly has Received Milestone Payment Following Dosing ...
iOnctura Strengthens Medical and Commercialization Expertise ...
Traumatic Brain Injury Market to Expand at a CAGR of 10.9% ...
Dragonfly Therapeutics Inc. anuncia una colaboraciĂłn clĂnica ...
Triple-Negative Breast Cancer Market Gearing Up for Impressive ...
Immunotherapy Drugs Market worth $580.6 billion by 2029 ...
Global Bispecific Antibody Therapeutics Contract Manufacturing ...
Aquinnah Pharmaceuticals Advances Oral Small Molecule Program ...
Dragonfly Therapeutics startet Phase 1/1b-Studie seiner ...
Simcere Zaiming and AbbVie Announce Partnership to Develop ...
Wearable Injectors Market Worth $15.1 Billion | MarketsandMarkets™ ...
Mild Cognitive Impairment Market is Predicted to Advance ...
Ichnos Glenmark Innovation and AbbVie Announce Exclusive ...
Bioconjugation Market to Hit USD 10.86 Billion by 2029 with ...
PIRAMAL PHARMA SOLUTIONS COMMEMORATES OPENING OF ITS ADC ...
Muscle Relaxant Drugs Market is expected to generate a revenue ...
Piramal Pharma Limited Announces Consolidated Results for ...